These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7334144)

  • 1. Toxicity secondary to meperidine in patients on monoamine oxidase inhibitors: a case report and critical review.
    Meyer D; Halfin V
    J Clin Psychopharmacol; 1981 Sep; 1(5):319-21. PubMed ID: 7334144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fatal drug interactions].
    Peeters-Asdourian C
    Rev Med Brux; 1986 Nov; 7(9):570. PubMed ID: 3809825
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Interactions with monoamine oxidase inhibitors.
    McGilchrist JM
    Br Med J; 1975 Sep; 3(5983):591-2. PubMed ID: 1174832
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of hyperthermia in the interaction between pethidine or imipramine and monoamine oxidase inhibitors.
    Gong NC; Rogers KJ
    Med J Malaysia; 1973 Jun; 27(4):280-3. PubMed ID: 4270786
    [No Abstract]   [Full Text] [Related]  

  • 5. Avoidable drug interaction, not meningitis.
    Knisely AS
    Lancet; 1987 Sep; 2(8559):639. PubMed ID: 2887937
    [No Abstract]   [Full Text] [Related]  

  • 6. MAOIs and anesthesia.
    Clark AG
    Can J Anaesth; 1996 Jun; 43(6):641. PubMed ID: 8773875
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of serotonin uptake and the toxic interaction between meperidine and monoamine oxidase inhibitors.
    Fuller RW; Snoody HD
    Toxicol Appl Pharmacol; 1975 Apr; 32(1):129-34. PubMed ID: 1135868
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of pethidine and morphine in the presence of monoamine oxidase inhibitors.
    Evans-Prosser CD
    Br J Anaesth; 1968 Apr; 40(4):279-82. PubMed ID: 5654977
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin reaction and its treatment.
    Hogan C
    Aust Fam Physician; 1997 Jan; 26(1):76-7. PubMed ID: 9009024
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of monoamine oxidase inhibitors in the treatment of elderly, depressed patients.
    Jenike MA
    J Am Geriatr Soc; 1984 Aug; 32(8):571-5. PubMed ID: 6747167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beware -- the use of MAO inhibitors is increasing again.
    Brown TC; Cass NM
    Anaesth Intensive Care; 1979 Feb; 7(1):65-8. PubMed ID: 434448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.
    Eade NR; Renton KW
    Biochem Pharmacol; 1970 Jul; 19(7):2243-50. PubMed ID: 5520372
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse drug interaction in dentistry.
    Kawakami O
    Dent Stud; 1969 May; 47(8):530-1 passim. PubMed ID: 5252940
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonin syndrome: a case report.
    Price WA; Zimmer B; Kucas P
    J Clin Pharmacol; 1986 Jan; 26(1):77-8. PubMed ID: 3950054
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine oxidase inhibitors and anaesthesia. A review.
    Stack CG; Rogers P; Linter SP
    Br J Anaesth; 1988 Feb; 60(2):222-7. PubMed ID: 3278728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.
    Boden R; Botting R; Coulson P; Spanswick G
    Br J Pharmacol; 1984 May; 82(1):151-4. PubMed ID: 6428496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of selective inhibitors of monoamine oxidase with pethidine in rabbits.
    Jounela AJ; Mattila MJ; Knoll J
    Biochem Pharmacol; 1977 Apr; 26(8):806-8. PubMed ID: 856214
    [No Abstract]   [Full Text] [Related]  

  • 18. Isoniazid, meperidine, and hypotension.
    Gannon R; Pearsall W; Rowley R
    Ann Intern Med; 1983 Sep; 99(3):415. PubMed ID: 6614704
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant.
    Smookler S; Bermudez AJ
    Ann Emerg Med; 1982 Sep; 11(9):482-4U. PubMed ID: 7114595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danger of MAOI therapy after fluoxetine withdrawal.
    Graham PM; Ilett KF
    Lancet; 1988 Nov; 2(8622):1255-6. PubMed ID: 2903989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.